Item request has been placed!
×
Item request cannot be made.
×
Processing Request
The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Dofuor AK;Dofuor AK; Quartey NK; Quartey NK; Osabutey AF; Osabutey AF; Boateng BO; Boateng BO; Lutuf H; Lutuf H; Osei JHN; Osei JHN; Ayivi-Tosuh SM; Ayivi-Tosuh SM; Aiduenu AF; Aiduenu AF; Ekloh W; Ekloh W; Loh SK; Loh SK; Opoku MJ; Opoku MJ; Aidoo OF; Aidoo OF
- المصدر:
Clinical pathology (Thousand Oaks, Ventura County, Calif.) [Clin Pathol] 2023 Dec 23; Vol. 16, pp. 2632010X231218075. Date of Electronic Publication: 2023 Dec 23 (Print Publication: 2023).- نوع النشر :
Journal Article; Review- اللغة:
English - المصدر:
- معلومة اضافية
- المصدر: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101741182 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-010X (Electronic) Linking ISSN: 2632010X NLM ISO Abbreviation: Clin Pathol Subsets: PubMed not MEDLINE
- بيانات النشر: Original Publication: [Thousand Oaks, CA] : SAGE Publications, [2019]-
- نبذة مختصرة : In December 2019, an outbreak of a respiratory disease called the coronavirus disease 2019 (COVID-19) caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China. The SARS-CoV-2, an encapsulated positive-stranded RNA virus, spread worldwide with disastrous consequences for people's health, economies, and quality of life. The disease has had far-reaching impacts on society, including economic disruption, school closures, and increased stress and anxiety. It has also highlighted disparities in healthcare access and outcomes, with marginalized communities disproportionately affected by the SARS-CoV-2. The symptoms of COVID-19 range from mild to severe. There is presently no effective cure. Nevertheless, significant progress has been made in developing COVID-19 vaccine for different therapeutic targets. For instance, scientists developed multifold vaccine candidates shortly after the COVID-19 outbreak after Pfizer and AstraZeneca discovered the initial COVID-19 vaccines. These vaccines reduce disease spread, severity, and mortality. The addition of rapid diagnostics to microscopy for COVID-19 diagnosis has proven crucial. Our review provides a thorough overview of the historical development of COVID-19 and molecular and biochemical characterization of the SARS-CoV-2. We highlight the potential contributions from insect and plant sources as anti-SARS-CoV-2 and present directions for future research.
Competing Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
(© The Author(s) 2023.) - References: Life Sci. 2020 Nov 15;261:118336. (PMID: 32846164)
Lancet. 2020 Feb 15;395(10223):514-523. (PMID: 31986261)
Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507)
N Engl J Med. 2021 Dec 9;385(24):e85. (PMID: 34706170)
Front Microbiol. 2022 Jul 14;13:927306. (PMID: 35910658)
N Engl J Med. 2022 Sep 15;387(11):1047-1049. (PMID: 36069818)
J Biomol Struct Dyn. 2022 Jun;40(9):3949-3964. (PMID: 33251972)
J Infect. 2012 Dec;65(6):477-89. (PMID: 23072791)
Acta Pharm Sin B. 2020 May;10(5):766-788. (PMID: 32292689)
Viruses. 2022 Apr 06;14(4):. (PMID: 35458489)
Int J Surg Open. 2020;26:125-136. (PMID: 34568614)
PLoS One. 2021 Oct 26;16(10):e0258643. (PMID: 34699552)
J Occup Environ Med. 2021 Mar 1;63(3):e159-e162. (PMID: 33405498)
Emerg Microbes Infect. 2020 Dec;9(1):2076-2090. (PMID: 32897177)
Saudi J Biol Sci. 2016 Jul;23(4):507-11. (PMID: 27298584)
Int Immunopharmacol. 2023 Feb;115:109650. (PMID: 36649673)
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):. (PMID: 33637653)
Heliyon. 2020 Dec;6(12):e05798. (PMID: 33363261)
Lancet. 2020 Feb 15;395(10223):470-473. (PMID: 31986257)
J Clin Med. 2020 Jun 30;9(7):. (PMID: 32629768)
PLoS Negl Trop Dis. 2018 Jul 30;12(7):e0006666. (PMID: 30059498)
Br Med Bull. 2011;100:137-55. (PMID: 21852279)
Biochimie. 2010 Dec;92(12):1749-59. (PMID: 20850496)
Metabol Open. 2021 Dec;12:100141. (PMID: 34693242)
Science. 2003 Oct 10;302(5643):276-8. (PMID: 12958366)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
Health Policy Technol. 2020 Dec;9(4):673-691. (PMID: 32874853)
Nat Rev Immunol. 2021 Oct;21(10):626-636. (PMID: 34373623)
Euro Surveill. 2020 Jan;25(3):. (PMID: 31992387)
Biosci Trends. 2020 Mar 16;14(1):64-68. (PMID: 32037389)
Afr Dev Rev. 2021 Apr;33(Suppl 1):S152-S164. (PMID: 38607838)
Int Immunopharmacol. 2020 Dec;89(Pt B):107088. (PMID: 33129099)
Dermatol Ther. 2020 Sep;33(5):e13549. (PMID: 32390279)
Can J Infect Dis Med Microbiol. 2022 Feb 9;2022:6913772. (PMID: 35186175)
J Biomol Struct Dyn. 2021 May;39(8):2971-2979. (PMID: 32306860)
Phytother Res. 2020 Oct;34(10):2471-2492. (PMID: 32248575)
Molecules. 2021 Feb 25;26(5):. (PMID: 33669054)
Front Public Health. 2021 Sep 29;9:738352. (PMID: 34660518)
J Chem Neuroanat. 2020 Dec;110:101874. (PMID: 33091590)
Clin Infect Dis. 2023 Jan 6;76(1):165-171. (PMID: 35245942)
J Infect Dis. 2021 Oct 28;224(8):1278-1286. (PMID: 34279629)
Acta Virol. 2020;64(4):496-500. (PMID: 32985209)
J Med Virol. 2022 Apr;94(4):1728-1733. (PMID: 34897752)
Mol Pharm. 2021 Mar 1;18(3):754-771. (PMID: 33464914)
Sci Rep. 2020 Jul 29;10(1):12732. (PMID: 32728118)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Surg Neurol Int. 2021 Jun 28;12:317. (PMID: 34345458)
Saudi Pharm J. 2020 Nov;28(11):1333-1352. (PMID: 32905015)
ACS Cent Sci. 2020 May 27;6(5):672-683. (PMID: 32483554)
J Med Virol. 2020 Apr;92(4):401-402. (PMID: 31950516)
Microorganisms. 2022 Jul 18;10(7):. (PMID: 35889169)
Front Nutr. 2022 Sep 29;9:934568. (PMID: 36245547)
Nat Methods. 2023 Apr;20(4):512-522. (PMID: 36823332)
J Gen Virol. 2021 Apr;102(4):. (PMID: 33830908)
Biomed Pharmacother. 2023 Jun;162:114367. (PMID: 37018987)
Med J Armed Forces India. 2020 Oct;76(4):370-376. (PMID: 32895599)
Viruses. 2022 Jul 15;14(7):. (PMID: 35891531)
N Engl J Med. 2022 Jan 20;386(3):264-272. (PMID: 34995029)
Lancet Respir Med. 2020 Dec;8(12):1201-1208. (PMID: 32861276)
Clin Chem. 2020 Jul 1;66(7):975-977. (PMID: 32315390)
Evid Based Complement Alternat Med. 2021 Oct 19;2021:5345821. (PMID: 34712342)
Indian J Med Res. 2020 May;151(5):444-449. (PMID: 32611915)
Eur J Radiol. 2022 Mar;148:110156. (PMID: 35078136)
Eur J Med Res. 2020 Aug 12;25(1):32. (PMID: 32787926)
Int J Mol Sci. 2022 Dec 10;23(24):. (PMID: 36555300)
Molecules. 2020 Oct 29;25(21):. (PMID: 33138197)
Dtsch Arztebl Int. 2021 Mar 5;118(9):145-151. (PMID: 33958032)
RNA Biol. 2012 Nov;9(11):1319-30. (PMID: 23064118)
Arch Dis Child. 2021 Jul 19;106(8):802-807. (PMID: 33334728)
Microbiol Res. 2022 Dec;265:127206. (PMID: 36162150)
Nature. 2021 Aug;596(7872):410-416. (PMID: 34252919)
Cell Discov. 2020 Mar 18;6:16. (PMID: 32194981)
J Enzyme Inhib Med Chem. 2021 Dec;36(1):497-503. (PMID: 33491508)
Phytother Res. 2021 Feb;35(2):743-750. (PMID: 32945590)
Hum Gene Ther. 2022 Jul;33(13-14):708-718. (PMID: 35272502)
Front Immunol. 2021 Dec 23;12:771011. (PMID: 35003088)
Malays J Pathol. 2020 Apr;42(1):13-21. (PMID: 32342927)
Phytomedicine. 2022 Apr;98:153930. (PMID: 35114450)
Ann Intern Med. 2021 Apr;174(4):511-520. (PMID: 33370173)
BMC Infect Dis. 2021 Jun 16;21(1):585. (PMID: 34134656)
Biosaf Health. 2020 Dec;2(4):217-225. (PMID: 33196035)
Thromb Res. 2020 Jul;191:26-27. (PMID: 32360977)
Sci Total Environ. 2020 Aug 1;728:138861. (PMID: 32344226)
Pharmaceuticals (Basel). 2021 Oct 28;14(11):. (PMID: 34832884)
N Engl J Med. 2021 Nov 4;385(19):1761-1773. (PMID: 34525277)
Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S223-7, discussion S226. (PMID: 16378050)
Int J Biol Sci. 2020 Mar 15;16(10):1686-1697. (PMID: 32226286)
J Virol. 2021 Mar 1;95(10):. (PMID: 33649194)
Pharmaceuticals (Basel). 2022 Aug 25;15(9):. (PMID: 36145270)
Front Pharmacol. 2021 May 07;12:675287. (PMID: 34025433)
Front Sociol. 2020 Oct 16;5:575791. (PMID: 33869502)
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093. (PMID: 34383730)
J Aerosol Med. 2007 Winter;20(4):484-94. (PMID: 18158720)
Euro Surveill. 2020 Jan;25(4):. (PMID: 32019669)
Pathogens. 2021 Mar 05;10(3):. (PMID: 33807556)
Pharmaceuticals (Basel). 2021 Jun 30;14(7):. (PMID: 34208847)
Biomed Pharmacother. 2019 Sep;117:109078. (PMID: 31181444)
Science. 2021 May 21;372(6544):815-821. (PMID: 33853970)
Biology (Basel). 2021 Sep 26;10(10):. (PMID: 34681059)
Appl Microbiol Biotechnol. 2021 Jan;105(2):441-455. (PMID: 33394144)
J Clin Microbiol. 2020 Apr 23;58(5):. (PMID: 32132196)
Int Rev Immunol. 2021;40(1-2):143-156. (PMID: 33439059)
BMJ. 2021 Jan 20;372:n84. (PMID: 33472855)
Clin Microbiol Rev. 2020 Jun 24;33(4):. (PMID: 32580969)
Expert Rev Clin Immunol. 2021 Jun;17(6):573-599. (PMID: 33787412)
N Engl J Med. 2021 Feb 4;384(5):403-416. (PMID: 33378609)
J Pharm Anal. 2020 Aug;10(4):313-319. (PMID: 32296570)
Am J Emerg Med. 2020 Jul;38(7):1504-1507. (PMID: 32317203)
mSystems. 2021 Aug 31;6(4):e0079321. (PMID: 34374562)
BMJ. 2020 Jan 20;368:m236. (PMID: 31959587)
Lancet Respir Med. 2021 May;9(5):511-521. (PMID: 33676589)
Nature. 2020 Jun;582(7813):469. (PMID: 32546811)
Arch Razi Inst. 2021 Sep 01;76(3):453-459. (PMID: 34824739)
Nat Commun. 2021 Jan 12;12(1):279. (PMID: 33436624)
Drugs Context. 2020 May 22;9:. (PMID: 32547625)
Dev Biol (Basel). 2004;119:129-40. (PMID: 15742624)
J Med Virol. 2020 Jun;92(6):538-539. (PMID: 32096564)
Int J Inf Technol. 2020;12(2):311-317. (PMID: 32412538)
Science. 2020 Nov 27;370(6520):1089-1094. (PMID: 33082295)
J Cell Physiol. 2021 Jul;236(7):5325-5338. (PMID: 33372280)
Signal Transduct Target Ther. 2020 Jun 10;5(1):89. (PMID: 32533062)
Clin Med (Lond). 2021 Jan;21(1):e54-e56. (PMID: 33243836)
Sci Rep. 2020 Nov 30;10(1):20818. (PMID: 33257702)
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4529-4536. (PMID: 32373991)
Lancet. 1966 Jan 8;1(7428):76-7. (PMID: 4158999)
Arch Virol. 2021 Mar;166(3):949-954. (PMID: 33492523)
Nat Commun. 2022 May 6;13(1):2494. (PMID: 35523782)
N Engl J Med. 2020 Dec 10;383(24):2320-2332. (PMID: 32877576)
Virol J. 2022 May 21;19(1):87. (PMID: 35597998)
Front Immunol. 2022 Jun 21;13:917905. (PMID: 35799790)
PLoS One. 2022 Jun 16;17(6):e0269997. (PMID: 35709075)
BMC Pulm Med. 2012 Mar 21;12:11. (PMID: 22436202)
Annu Rev Virol. 2021 Sep 29;8(1):51-72. (PMID: 34586874)
J Med Virol. 2020 Apr;92(4):418-423. (PMID: 31967327)
Anal Chem. 2021 Aug 10;93(31):10955-10965. (PMID: 34323465)
Virol J. 2022 Mar 19;19(1):50. (PMID: 35305688)
Comput Biol Med. 2022 Mar;142:105228. (PMID: 35051855)
Clin Microbiol Infect. 2020 Jun;26(6):773-779. (PMID: 32276116)
MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):389-395. (PMID: 33735162)
Nat Microbiol. 2020 Apr;5(4):536-544. (PMID: 32123347)
EBioMedicine. 2022 Jan;75:103736. (PMID: 34922321)
J Biol Eng. 2019 Oct 23;13:78. (PMID: 31666806)
Adv Exp Med Biol. 2021;1327:191-195. (PMID: 34279839)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
J Aerosol Sci. 2020 Sep;147:105585. (PMID: 32427227)
Foods. 2021 Feb 10;10(2):. (PMID: 33578926)
Sci Rep. 2017 May 25;7(1):2409. (PMID: 28546538)
Front Cell Dev Biol. 2020 Jul 10;8:618. (PMID: 32754600)
Biomed Pharmacother. 2020 Oct;130:110532. (PMID: 32707440)
Int Immunopharmacol. 2020 Dec;89(Pt A):107018. (PMID: 33045577)
J Nat Prod. 2021 Apr 23;84(4):1261-1270. (PMID: 33844528)
Arch Med Res. 2014 Jul;45(5):359-65. (PMID: 24880005)
JAMA. 2020 Apr 28;323(16):1610-1612. (PMID: 32129805)
Clin Imaging. 2021 Aug;76:6-14. (PMID: 33545517)
Clin Toxicol (Phila). 2019 Aug;57(8):677-685. (PMID: 30806093)
Viruses. 2021 Feb 23;13(2):. (PMID: 33672333)
Proc Soc Exp Biol Med. 1966 Jan;121(1):190-3. (PMID: 4285768)
J Clin Virol. 2022 Oct;155:105246. (PMID: 35930858)
NPJ Sci Food. 2020 Oct 5;4:17. (PMID: 33083549)
Dose Response. 2021 Mar 30;19(1):1559325820982423. (PMID: 33867892)
Lancet Glob Health. 2019 Aug;7(8):e1031-e1045. (PMID: 31303294)
Ghana Med J. 2020 Dec;54(4 Suppl):23-32. (PMID: 33976438)
Radiology. 2020 Aug;296(2):E32-E40. (PMID: 32101510)
Clin Microbiol Infect. 2020 Jun;26(6):791-792. (PMID: 32246996)
N Engl J Med. 2020 Apr 16;382(16):1564-1567. (PMID: 32182409)
JMIR Mhealth Uhealth. 2020 Aug 28;8(8):e19857. (PMID: 32759102)
China CDC Wkly. 2020 Jan 24;2(4):61-62. (PMID: 34594763)
Int J Mol Med. 2020 Sep;46(3):957-964. (PMID: 32705153)
JAMA Netw Open. 2020 Jun 1;3(6):e2011834. (PMID: 32525550)
Chest. 2020 Oct;158(4):1397-1408. (PMID: 32553536)
Engineering (Beijing). 2022 Dec;19:139-152. (PMID: 34729244)
Acta Virol. 2020;64(3):276-280. (PMID: 32985211)
Ther Adv Musculoskelet Dis. 2010 Oct;2(5):247-56. (PMID: 22870451)
Viruses. 2021 Jul 30;13(8):. (PMID: 34452373)
Future Virol. 2022 Jun;:. (PMID: 35812188)
N Engl J Med. 2020 Nov 5;383(19):1813-1826. (PMID: 32445440)
Pharmaceutics. 2022 Apr 13;14(4):. (PMID: 35456687)
Clin Chim Acta. 2020 Sep;508:254-266. (PMID: 32474009)
Front Biosci (Landmark Ed). 2021 Oct 30;26(10):789-798. (PMID: 34719206)
Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):293-306. (PMID: 34511220)
JAMA. 2020 May 12;323(18):1843-1844. (PMID: 32159775)
Drugs. 2022 Apr;82(5):585-591. (PMID: 35305258)
Indian J Ophthalmol. 2020 May;68(5):693-702. (PMID: 32317431)
Vaccines (Basel). 2021 Dec 20;9(12):. (PMID: 34960250)
Front Public Health. 2021 Sep 08;9:719914. (PMID: 34568261)
Mol Biotechnol. 2022 Nov;64(11):1177-1197. (PMID: 35488142)
J Med Virol. 2020 Jul;92(7):797-806. (PMID: 32198776)
Sci Rep. 2021 Jan 12;11(1):780. (PMID: 33436939)
N Engl J Med. 2021 Apr 22;384(16):1503-1516. (PMID: 33631066)
Curr Gastroenterol Rep. 2020 Feb 10;22(3):12. (PMID: 32040650)
Clin Microbiol Infect. 2020 Jul;26(7):954-956. (PMID: 32229288)
Int J Infect Dis. 2020 Oct;99:328-333. (PMID: 32497809)
Front Immunol. 2021 Sep 03;12:711741. (PMID: 34539642)
Phytother Res. 2021 Mar;35(3):1127-1129. (PMID: 33222316)
Clin Exp Med. 2020 Nov;20(4):493-506. (PMID: 32720223)
J Mol Diagn. 2020 Jun;22(6):729-735. (PMID: 32276051)
Biol Proced Online. 2020 Aug 4;22:19. (PMID: 32774178)
Radiology. 2020 Jun;295(3):715-721. (PMID: 32053470)
Cell Biosci. 2021 Aug 30;11(1):168. (PMID: 34461999)
Annu Rev Med. 2022 Jan 27;73:17-39. (PMID: 34669432)
Science. 2021 Sep 17;373(6561):1372-1377. (PMID: 34385356)
J Travel Med. 2020 Mar 13;27(2):. (PMID: 32052841)
Nature. 2020 Mar;579(7798):265-269. (PMID: 32015508) - Contributed Indexing: Keywords: COVID-19; SARS-CoV-2; drug discovery; epidemiology; insects; plants
- الموضوع: Date Created: 20231225 Latest Revision: 20241019
- الموضوع: 20241019
- الرقم المعرف: PMC10748929
- الرقم المعرف: 10.1177/2632010X231218075
- الرقم المعرف: 38144436
- المصدر:
حقوق النشر© 2024، دائرة الثقافة والسياحة جميع الحقوق محفوظة Powered By EBSCO Stacks 3.3.0 [353] | Staff Login
حقوق النشر © دائرة الثقافة والسياحة، جميع الحقوق محفوظة
No Comments.